Keloids and hypertrophic scars:: Are they two different sides of the same coin?

被引:147
作者
Koese, Osman [1 ,2 ,3 ]
Waseem, Ahmad [2 ,3 ]
机构
[1] Gulhane Mil Med Acad, Dept Dermatol, TR-06018 Ankara, Turkey
[2] Programme Muco Cutaneous Oncol, Dept Clin & Diagnost Oral Sci, Barts, England
[3] London Queen Marys Sch Med & Dent, London, England
关键词
D O I
10.1111/j.1524-4725.2007.34067.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Keloids and hypertrophic scars are different forms of excessive dermal fibrosis thought to be caused by regulation of cellularity increase and decrease during the wound-healing process in predisposed individuals. Differences between keloids and hypertrophic scars include distinct clinical features, histologic evidence, and cellular function in response to molecular events. Keloids and hypertrophic scars are the results of increased fibroblast density and extracellular matrix substances. Interactions between epidermal keratinocytes and dermal fibroblasts play an important role in regulating tissue homeostasis and processing scar formation. Keloids and hypertrophic scars are the two different stages of the same process that is based on separate clinical and histochemical entities. The aim of this review is to provide updated information regarding similarities and differences between keloids and hypertrophic scars as two different sides of the same coin. This article will also enable the dermatologist to better understand fundamental biology of the scarring.
引用
收藏
页码:336 / 346
页数:11
相关论文
共 64 条
[1]
Adriessen MP, 1998, J PATHOL, V186, P192, DOI 10.1002/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO
[2]
2-X
[3]
Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma [J].
Akasaka, Y ;
Fujita, K ;
Ishikawa, Y ;
Asuwa, N ;
Inuzuka, K ;
Ishihara, M ;
Ito, M ;
Masuda, T ;
Akishima, Y ;
Zhang, LJ ;
Ito, K ;
Ishii, T .
WOUND REPAIR AND REGENERATION, 2001, 9 (06) :501-506
[4]
Keloid pathogenesis and treatment [J].
Al-Attar, A ;
Mess, S ;
Thomassen, JM ;
Kauffman, CL ;
Davison, SP .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (01) :286-300
[5]
Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids [J].
Amadeu, TP ;
Braune, AS ;
Porto, LC ;
Desmoulière, A ;
Costa, AMA .
WOUND REPAIR AND REGENERATION, 2004, 12 (02) :169-174
[6]
Keloid or hypertrophic scar - The controversy: Review of the literature [J].
Atiyeh, BS ;
Costagliola, M ;
Hayek, SA .
ANNALS OF PLASTIC SURGERY, 2005, 54 (06) :676-680
[7]
Mast cells in pathological and surgical scars [J].
Beer, TW ;
Baldwin, H ;
West, L ;
Gallagher, PJ ;
Wright, DH .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (06) :691-694
[8]
Imiquimod 5% cream for keloid management [J].
Berman, B ;
Villa, A .
DERMATOLOGIC SURGERY, 2003, 29 (10) :1050-1051
[9]
THE DISTRIBUTION OF HYALURONAN IN HUMAN SKIN AND MATURE, HYPERTROPHIC AND KELOID SCARS [J].
BERTHEIM, U ;
HELLSTROM, S .
BRITISH JOURNAL OF PLASTIC SURGERY, 1994, 47 (07) :483-489
[10]
The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis [J].
Bettinger, DA ;
Yager, DR ;
Diegelmann, RF ;
Cohen, IK .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1996, 98 (05) :827-833